Bandhan Focused Fund
The scheme aims to generate capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of upto 30 stocks.
Growthvine rating: 2/5 — ranked #19 of 28 in category.
Fund basics
| Category | Equity: Focused |
|---|
| NAV | ₹92.62 (as of 2026-11-13) |
|---|
| AUM | ₹2,087 Cr |
|---|
| Expense ratio | 1.76% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Kirthi Jain |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 9.32% |
|---|
| Sharpe ratio | 0.48 |
|---|
| Standard deviation | 16.82% |
|---|
| Max drawdown | −39.22% |
|---|
| Alpha | 3.24 |
|---|
| Beta | 0.96 |
|---|
Over 5 years, captured 98.1% of Nifty 500's upside and 93.5% of its downside.
Market cap allocation
| Large cap | 40.4% |
|---|
| Mid cap | 11.8% |
|---|
| Small cap | 47.8% |
|---|
Concentration
| Top 5 holdings | 33.8% |
|---|
| Top 10 holdings | 58.3% |
|---|
| Total holdings | 29 |
|---|
| Index overlap | 26.2% |
|---|
| Active share | 73.8% |
|---|
Top holdings
- LT Foods Limited — 8.1%
- EPL LIMITED — 6.9%
- Prestige Estates Projects Limited — 6.5%
- HDFC Bank Ltd. — 6.4%
- JUBILANT PHARMOVA LIMITED — 5.9%
- CHOLAMANDALAM FINANCIAL HOLDINGS LIMITED — 5.5%
- Reliance Industries Ltd — 5.3%
- Power Finance Corporation Ltd — 5.0%
- Glenmark Pharmaceuticals ltd — 4.9%
- Sanathan Textiles Limited — 3.8%
Top sectors
- Banking & Financial — 18.0%
- Retail — 12.2%
- Pharma & Biotech — 10.9%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 5.4% | Q2 | #10 of 28 |
| 2025 | −1.6% | Q4 (Bottom) | #24 of 28 |
| 2024 | 30.3% | Q1 (Top) | #2 of 27 |
| 2023 | 31.3% | Q1 (Top) | #4 of 25 |
| 2022 | −5.0% | Q4 (Bottom) | #18 of 22 |